Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 60 | 1 | 54 | −5 |
| Shares | 5.41M | 1.42M | 5.30M | +1.31M (+32.9%) |
| Value | $7.36M | $1.93M | $5.27M | −$150.5K (−2.8%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 1,255,516 | $1.25M | 0.00% |
| Vanguard Fiduciary Trust Co | 160,265 | $159.5K | 0.00% |
| Gerald Baker Financial Group LLC | 22,691 | $22.6K | 0.01% |
| Virtu Financial LLC | 12,324 | $12.0K | 0.00% |
| Vanguard Global Advisers, LLC | 8,893 | $8.85K | 0.00% |
| Advisory Services Network, LLC | 1,460 | $1.45K | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% |
Sold out (12)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Two Sigma Advisers, LP | 196,076 | $266.7K |
| Squarepoint Ops LLC | 65,730 | $89.4K |
| Bailard, Inc. | 57,867 | $78.7K |
| Cetera Investment Advisers | 15,259 | $20.8K |
| Russell Investments Group, Ltd. | 13,340 | $18.1K |
| HRT Financial LP | 13,010 | $17.0K |
| Point72 Asset Management, L.P. | 10,295 | $14.0K |
| SRS Capital Advisors, Inc. | 707 | $962 |
| Bank of America Corp | 649 | $882 |
| EverSource Wealth Advisors, LLC | 16 | $22 |
| Essential Partners LLC | 4 | $5 |
| Barclays PLC | 1 | $1 |
Not filed for Q1 2026 yet (1)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,421,038 | $1.93M |